ESR1 and breast carcinoma: On the contrary, the levels of AKT3 mRNA, protein, and enzymatic activity are significantly increased in estrogen receptor negative (ER−) and triple negative (ER−, Progesterone Receptor negative, Her2/neu negative; ER−PR−Her2/neu−) breast cancers, promoting cell proliferation and tumor growth [26].